Matches in SemOpenAlex for { <https://semopenalex.org/work/W2939113095> ?p ?o ?g. }
Showing items 1 to 91 of
91
with 100 items per page.
- W2939113095 abstract "Background Polymorphisms in IKZF1 (Ikaros) and IKZF3 (Aiolos), which are transcriptions factors essential for B cell activation, maturation and differentiation, have been associated with Systemic Lupus Erythematosus (SLE). However the functional role of IKZF1 and IKZF3 in the context of failed B cell checkpoints and aberrant plasmablast development in SLE has not been previously characterised. Iberdomide (a cereblon modulator) known to induce the degradation of transcription factors IKZF1 and IKZF3 is being explored as a therapeutic target for SLE. The aim of this study was to utilise iberdomide to evaluate the effect of inhibition of IKZF1 and IKZF3 on transcriptional programmes underlying B cell differentiation, gene expression and immunoglobulin production in SLE B cells. Methods CD19 +B cells were isolated from peripheral blood of 25 SLE patients and stimulated with IL-2, IL-10, IL-15, CD40L and TLR7 ligand Resiquimod for 5 days to induce plasmablast differentiation. In separate studies, B cells were treated from the outset with iberdomide (10 nM) or vehicle and subsequently differentiated, or differentiated plasmablasts (day 4) were treated with iberdomide or vehicle for 18 hour. Treated plasmablasts underwent fluorescence-activated cell sorting (FACS), and IgG/IgM secretion analysed with ELISA. FACS-sorted CD27-IgD+naive B cells and CD20lowCD27+CD38+plasmablasts were subjected to bulk ultra-low input RNA-seq along with matched baseline B cells. Unsupervised clustering, differential gene expression and pathway analysis were performed on transcriptome data. Results Day 0 iberdomide (n=9), but not day 4 iberdomide (n=16), significantly reduced the CD20lowCD27+CD38+plasmablast numbers following cell culture (p=0.03). Similarly, Day 0 iberdomide significantly decreased supernatant IgG/IgM concentrations (p=0.050 and 0.017, respectively), but not day 4 iberdomide. RNA-seq of sorted naive B cells and plasmablasts cultured with day 4 iberdomide demonstrated significant differential gene expression in both populations (400 and 461 differentially modulated genes in naive B cells and plasmablasts, FDR-adjusted p Conclusions Iberdomide exposure significantly blocked SLE B cell differentiation into plasmablasts, but did not alter fully differentiated plasmablast viability, confirming the role of IKZF1 and IKZF3 in the process of B cell differentiation into aberrant plasmablasts in SLE. Our study demonstrates that IKZF1 and IKZF3 inhibition results in differential expression of key B cell development transcriptional gene modules in both SLE naive B cells and plasmablasts. Funding Source(s): This study was supported by research funding from Celgene Corporation." @default.
- W2939113095 created "2019-04-25" @default.
- W2939113095 creator A5002044306 @default.
- W2939113095 creator A5017572254 @default.
- W2939113095 creator A5025720474 @default.
- W2939113095 creator A5027183021 @default.
- W2939113095 creator A5038945821 @default.
- W2939113095 creator A5043661588 @default.
- W2939113095 creator A5049326244 @default.
- W2939113095 creator A5050503305 @default.
- W2939113095 creator A5052603386 @default.
- W2939113095 date "2019-04-01" @default.
- W2939113095 modified "2023-09-23" @default.
- W2939113095 title "235 IKZF1 and IKZF3 inhibition impairs B cell differentiation and modulates gene expression in systemic lupus erythematosus" @default.
- W2939113095 doi "https://doi.org/10.1136/lupus-2019-lsm.235" @default.
- W2939113095 hasPublicationYear "2019" @default.
- W2939113095 type Work @default.
- W2939113095 sameAs 2939113095 @default.
- W2939113095 citedByCount "0" @default.
- W2939113095 crossrefType "proceedings-article" @default.
- W2939113095 hasAuthorship W2939113095A5002044306 @default.
- W2939113095 hasAuthorship W2939113095A5017572254 @default.
- W2939113095 hasAuthorship W2939113095A5025720474 @default.
- W2939113095 hasAuthorship W2939113095A5027183021 @default.
- W2939113095 hasAuthorship W2939113095A5038945821 @default.
- W2939113095 hasAuthorship W2939113095A5043661588 @default.
- W2939113095 hasAuthorship W2939113095A5049326244 @default.
- W2939113095 hasAuthorship W2939113095A5050503305 @default.
- W2939113095 hasAuthorship W2939113095A5052603386 @default.
- W2939113095 hasBestOaLocation W29391130951 @default.
- W2939113095 hasConcept C10205521 @default.
- W2939113095 hasConcept C141105273 @default.
- W2939113095 hasConcept C154317977 @default.
- W2939113095 hasConcept C159654299 @default.
- W2939113095 hasConcept C159912055 @default.
- W2939113095 hasConcept C202751555 @default.
- W2939113095 hasConcept C203014093 @default.
- W2939113095 hasConcept C2778453870 @default.
- W2939113095 hasConcept C2778957590 @default.
- W2939113095 hasConcept C28328180 @default.
- W2939113095 hasConcept C34814297 @default.
- W2939113095 hasConcept C39347974 @default.
- W2939113095 hasConcept C48010095 @default.
- W2939113095 hasConcept C54355233 @default.
- W2939113095 hasConcept C71924100 @default.
- W2939113095 hasConcept C86803240 @default.
- W2939113095 hasConcept C95444343 @default.
- W2939113095 hasConceptScore W2939113095C10205521 @default.
- W2939113095 hasConceptScore W2939113095C141105273 @default.
- W2939113095 hasConceptScore W2939113095C154317977 @default.
- W2939113095 hasConceptScore W2939113095C159654299 @default.
- W2939113095 hasConceptScore W2939113095C159912055 @default.
- W2939113095 hasConceptScore W2939113095C202751555 @default.
- W2939113095 hasConceptScore W2939113095C203014093 @default.
- W2939113095 hasConceptScore W2939113095C2778453870 @default.
- W2939113095 hasConceptScore W2939113095C2778957590 @default.
- W2939113095 hasConceptScore W2939113095C28328180 @default.
- W2939113095 hasConceptScore W2939113095C34814297 @default.
- W2939113095 hasConceptScore W2939113095C39347974 @default.
- W2939113095 hasConceptScore W2939113095C48010095 @default.
- W2939113095 hasConceptScore W2939113095C54355233 @default.
- W2939113095 hasConceptScore W2939113095C71924100 @default.
- W2939113095 hasConceptScore W2939113095C86803240 @default.
- W2939113095 hasConceptScore W2939113095C95444343 @default.
- W2939113095 hasLocation W29391130951 @default.
- W2939113095 hasOpenAccess W2939113095 @default.
- W2939113095 hasPrimaryLocation W29391130951 @default.
- W2939113095 hasRelatedWork W1993520417 @default.
- W2939113095 hasRelatedWork W2265479587 @default.
- W2939113095 hasRelatedWork W2403449504 @default.
- W2939113095 hasRelatedWork W2409183885 @default.
- W2939113095 hasRelatedWork W2547796740 @default.
- W2939113095 hasRelatedWork W2560676803 @default.
- W2939113095 hasRelatedWork W2561193199 @default.
- W2939113095 hasRelatedWork W2562357907 @default.
- W2939113095 hasRelatedWork W2564210718 @default.
- W2939113095 hasRelatedWork W2592564368 @default.
- W2939113095 hasRelatedWork W2594213988 @default.
- W2939113095 hasRelatedWork W2734403000 @default.
- W2939113095 hasRelatedWork W2741043676 @default.
- W2939113095 hasRelatedWork W2744316376 @default.
- W2939113095 hasRelatedWork W2767373004 @default.
- W2939113095 hasRelatedWork W2912090722 @default.
- W2939113095 hasRelatedWork W2913389650 @default.
- W2939113095 hasRelatedWork W2979102367 @default.
- W2939113095 hasRelatedWork W2980735343 @default.
- W2939113095 hasRelatedWork W3047377222 @default.
- W2939113095 isParatext "false" @default.
- W2939113095 isRetracted "false" @default.
- W2939113095 magId "2939113095" @default.
- W2939113095 workType "article" @default.